Metabolomics in hypertrophic cardiomyopathy and other myocardial diseases
Despite the clinical importance of hypertrophic cardiomyopathy (HCM) and a recognition that aberrant energetics contributes to its pathogenesis, significant uncertainty remains regarding the determinants of the clinical phenotype. The central hypothesis underlying this thesis is that the clinical ma...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Oxford
2015
|
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.730537 |